{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:16:28Z","timestamp":1777479388915,"version":"3.51.4"},"reference-count":16,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2014,12,18]],"date-time":"2014-12-18T00:00:00Z","timestamp":1418860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Appl Thromb Hemost"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:p>Selective intensification of platelet inhibition may improve high on treatment platelet reactivity (HPR). We evaluated the efficacy of dual-antiplatelet therapy, including clopidogrel (CPG), compared to new P2Y12-receptor antagonists in patients with HPR undergoing percutaneous coronary intervention, regarding the outcome of composite major adverse cardiac events (MACEs, including death, acute coronary syndrome [ACS], and stent restenosis). The presence of HPR (71 of 181 patients) almost doubled the risk of MACEs. The new antiplatelet agent reduced MACEs (45.8%, 26%, and 16.7% for CPG, prasugrel, and ticagrelor [TGL]; RR 0.36; 0.13-0.98, P = .03, TGL), specifically in patients with ACS. Failure to reduce HPR after the antiplatelet change and diabetes were independent predictors for MACEs. The HPR was early and effectively reduced after changing the antiplatelet therapy, but the intensity of this reduction did not significantly decrease the risk of MACEs. These findings support the benefit of HPR-guided intensification of platelet inhibition. Whether the intensity of this reduction improves the patient\u2019s clinical outcomes deserves further investigation.<\/jats:p>","DOI":"10.1177\/1076029614564208","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T05:28:57Z","timestamp":1418966937000},"page":"619-625","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Change to New P2Y12 Receptor Antagonists in Patients High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1177","volume":"21","author":[{"given":"Rogelio","family":"Robledo-Nolasco","sequence":"first","affiliation":[{"name":"Servicio de Hemodinamia, Departamento de Cardiolog\u00eday, Centro M\u00e9dico Nacional \u201c20 de Noviembre\u201d ISSSTE, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"God\u00ednez-Montes de Oca","sequence":"additional","affiliation":[{"name":"Servicio de Hemodinamia, Departamento de Cardiolog\u00eday, Centro M\u00e9dico Nacional \u201c20 de Noviembre\u201d ISSSTE, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F.","family":"Zaballa-Contreras","sequence":"additional","affiliation":[{"name":"Servicio de Hemodinamia, Departamento de Cardiolog\u00eday, Centro M\u00e9dico Nacional \u201c20 de Noviembre\u201d ISSSTE, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Su\u00e1rez-Cuenca","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Investigaci\u00f3n Biom\u00e9dica y Cl\u00ednica, Centro M\u00e9dico Nacional \u201c20 de Noviembre\u201d ISSSTE, Mexico City, Mexico"},{"name":"Clinical Research Unit, Hospital General de Ticom\u00e1n and Mexican Group for Basic and Clinical Research in Internal Medicine, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mondrag\u00f3n-Ter\u00e1n","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Investigaci\u00f3n Biom\u00e9dica y Cl\u00ednica, Centro M\u00e9dico Nacional \u201c20 de Noviembre\u201d ISSSTE, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"Rubio-Guerra","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Hospital General de Ticom\u00e1n and Mexican Group for Basic and Clinical Research in Internal Medicine, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Mel\u00e9ndez-Alc\u00e1ntara","sequence":"additional","affiliation":[{"name":"Servicio de Hemodinamia, Departamento de Cardiolog\u00eday, Centro M\u00e9dico Nacional \u201c20 de Noviembre\u201d ISSSTE, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,12,18]]},"reference":[{"key":"bibr1-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.100"},{"key":"bibr2-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2012.01.009"},{"key":"bibr3-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.02.024"},{"key":"bibr4-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-10-0874"},{"key":"bibr5-1076029614564208","volume-title":"The Antiplatelet Debate: Experts Juggle the Factors at CRT 2013","author":"Gurbel PA.","year":"2013"},{"key":"bibr6-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.030"},{"issue":"1","key":"bibr7-1076029614564208","first-page":"23","volume":"3","author":"Garabedian T","year":"2013","journal-title":"Cardiovasc Diagn Ther"},{"key":"bibr8-1076029614564208","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20130044"},{"key":"bibr9-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.059"},{"key":"bibr10-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.12.023"},{"issue":"2","key":"bibr11-1076029614564208","first-page":"130","volume":"2013","author":"Elmahdy MF","year":"2013","journal-title":"Glob Cardiol Sci Pract"},{"key":"bibr12-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.332"},{"key":"bibr13-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.02.026"},{"issue":"6","key":"bibr14-1076029614564208","first-page":"15","volume":"1","author":"Gurbel PA","year":"2012","journal-title":"J R Soc Med Cardiovasc Dis"},{"key":"bibr15-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"bibr16-1076029614564208","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327"}],"container-title":["Clinical and Applied Thrombosis\/Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1076029614564208","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1076029614564208","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1076029614564208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:05:37Z","timestamp":1777385137000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1076029614564208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,18]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1177\/1076029614564208"],"URL":"https:\/\/doi.org\/10.1177\/1076029614564208","relation":{},"ISSN":["1076-0296","1938-2723"],"issn-type":[{"value":"1076-0296","type":"print"},{"value":"1938-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,18]]}}}